7-146116535-AT-A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1
The ENST00000625365.2(CNTNAP2):c.-229-112delT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0374 in 227,172 control chromosomes in the GnomAD database, including 211 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.030 ( 198 hom., cov: 31)
Exomes 𝑓: 0.051 ( 13 hom. )
Consequence
CNTNAP2
ENST00000625365.2 intron
ENST00000625365.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.132
Publications
0 publications found
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
- cortical dysplasia-focal epilepsy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP6
Variant 7-146116535-AT-A is Benign according to our data. Variant chr7-146116535-AT-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 359164.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Benign=1}.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0976 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNTNAP2 | ENST00000625365.2 | c.-229-112delT | intron_variant | Intron 1 of 3 | 5 | ENSP00000485955.1 |
Frequencies
GnomAD3 genomes AF: 0.0296 AC: 4252AN: 143810Hom.: 199 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
4252
AN:
143810
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0508 AC: 4233AN: 83302Hom.: 13 Cov.: 0 AF XY: 0.0492 AC XY: 2096AN XY: 42628 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
4233
AN:
83302
Hom.:
Cov.:
0
AF XY:
AC XY:
2096
AN XY:
42628
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
447
AN:
3210
American (AMR)
AF:
AC:
205
AN:
3550
Ashkenazi Jewish (ASJ)
AF:
AC:
159
AN:
3190
East Asian (EAS)
AF:
AC:
339
AN:
7048
South Asian (SAS)
AF:
AC:
146
AN:
2996
European-Finnish (FIN)
AF:
AC:
202
AN:
4742
Middle Eastern (MID)
AF:
AC:
14
AN:
396
European-Non Finnish (NFE)
AF:
AC:
2436
AN:
52618
Other (OTH)
AF:
AC:
285
AN:
5552
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.286
Heterozygous variant carriers
0
439
878
1317
1756
2195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0297 AC: 4266AN: 143870Hom.: 198 Cov.: 31 AF XY: 0.0299 AC XY: 2092AN XY: 69878 show subpopulations
GnomAD4 genome
AF:
AC:
4266
AN:
143870
Hom.:
Cov.:
31
AF XY:
AC XY:
2092
AN XY:
69878
show subpopulations
African (AFR)
AF:
AC:
3951
AN:
39436
American (AMR)
AF:
AC:
160
AN:
14510
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3360
East Asian (EAS)
AF:
AC:
25
AN:
4842
South Asian (SAS)
AF:
AC:
32
AN:
4518
European-Finnish (FIN)
AF:
AC:
10
AN:
8700
Middle Eastern (MID)
AF:
AC:
1
AN:
272
European-Non Finnish (NFE)
AF:
AC:
39
AN:
65334
Other (OTH)
AF:
AC:
47
AN:
2006
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
189
378
566
755
944
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Cortical dysplasia-focal epilepsy syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Pitt-Hopkins-like syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Aug 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.